Pharma BD Deal Intelligence
Endo Health Solutions Inc. / Boca Pharmacal LLC
2013 · Acquisition/Merger · $225M · Complete
Announcement Sentiment
92
Strongly positive
Endo's Qualitest subsidiary to acquire Boca Pharmacal for ~$225M cash; added niche specialty generics (controlled substances, semisolids, solutions); expected $50M 2013 EBITDA.
Did it work? Outcome assessment
Strategic verdict
Failed to Achieve
Financial impact
Impaired/Written Down
Assessment window: 10yr post-close.
Key facts
- Announced Aug 28, 2013
- Closed Feb 03, 2014
- Deal value $225M
- Deal type Acquisition/Merger
- Therapeutic area Generic prescription specialty
- Indications Generic prescription specialty
- Key assets Specialty generics (controlled substances, semisolids, solutions)
- Mechanism Mixed niche generic dosage forms
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals